Impact of SARS-CoV-2 vaccination and booster on COVID-19 symptom severity over time in the COVID-OUT trial
Vaccination against SARS-CoV-2 was associated with reduced Covid-19 symptom severity in a sample of low to moderate risk adults who were enrolled in an outpatient Covid-19 treatment trial. Boosting was associated with further reduction in symptoms . Graphical Abstract
Gespeichert in:
Veröffentlicht in: | Clinical infectious diseases 2022-09 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Vaccination against SARS-CoV-2 was associated with reduced Covid-19 symptom severity in a sample of low to moderate risk adults who were enrolled in an outpatient Covid-19 treatment trial. Boosting was associated with further reduction in symptoms
.
Graphical Abstract |
---|---|
ISSN: | 1058-4838 1537-6591 |
DOI: | 10.1093/cid/ciac772 |